Clinical Trials Directory

Trials / Conditions / Stage III Skin Melanoma

Stage III Skin Melanoma

7 registered clinical trials studyying Stage III Skin Melanoma.

StatusTrialSponsorPhase
CompletedAcceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partn
NCT03112668
Rutgers, The State University of New JerseyN/A
CompletedTrigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malig
NCT03229278
Rutgers, The State University of New JerseyPhase 1
CompletedHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
NCT03154190
Stanford UniversityN/A
CompletedInteractive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
NCT03028948
Rutgers, The State University of New JerseyN/A
UnknownStudy to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients
NCT02437279
The Netherlands Cancer InstitutePhase 1
CompletedMEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma
NCT00866177
National Cancer Institute (NCI)Phase 2
CompletedBevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
NCT00387751
National Cancer Institute (NCI)Phase 2